Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

NCT03315130 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Myasthenia Gravis

Interventions

DRUG: zilucoplan (RA101495)
DRUG: Placebo

Sponsor

Ra Pharmaceuticals